Edition:
United States

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

76.49USD
20 Oct 2017
Change (% chg)

$1.86 (+2.49%)
Prev Close
$74.63
Open
$75.10
Day's High
$76.50
Day's Low
$74.53
Volume
2,292,961
Avg. Vol
1,440,264
52-wk High
$88.58
52-wk Low
$69.30

Select another date:

Wed, Oct 18 2017

CORRECTED-UPDATE 2-Health insurer Anthem takes pharmacy business in house, taps CVS to help

Oct 18 Health insurer Anthem Inc will start managing its billions of dollars of patient prescriptions itself in 2020, it said on Wednesday, ending a deal with Express Scripts Holding that had deteriorated into lawsuits over terms.

BRIEF-CVS Health signs five-year agreement with Anthem

* CVS Health signs five-year agreement with anthem, inc. To provide services to support ingeniorx

Anthem signs agreement with CVS Health for new PBM business

Oct 18 Drug retailer CVS Health Corp said on Wednesday it entered into an agreement with Anthem Inc to provide services to the health insurer's newly launched pharmacy benefit management (PBM) business, IngenioRx.

Drug chains tumble on reports Amazon eyeing their pie

Shares of drug retailers Walgreens Boots Alliance Inc , CVS Health Corp and Rite Aid Corp tumbled on Friday after reports that Amazon.com Inc was looking to make a move into selling drugs online.

BRIEF-CVS Health responds to opioid situation in the U.S.

* Says "in addition to our legacy opioid-abuse prevention programs, we are adding a new suite of tools‍​"‍​

CVS defeats generic drug overcharging class action

By Nate Raymond A federal judge has dismissed a class action lawsuit accusing pharmacy chain CVS Health Corp of systematically overcharging people who bought generic drugs using insurance rather than cash.

CVS Health's dull third-quarter forecast overshadows profit beat

CVS Health Corp forecast current quarter profit below Wall Street estimates and said it has been ordered to cooperate with investigations into possible false claims submitted to a government healthcare program and drug pricing.

UPDATE 3-CVS Health's dull Q3 forecast overshadows profit beat

* Shares down 1.4 pct (Adds investor comment, company response; updates shares)

BRIEF-CVS Health received civil investigative demand from Attorney General of Minnesota

* CVS Health Corp - in July 2017, co received a civil investigative demand from the attorney general of Minnesota - sec filing

BRIEF-CVS Health reports Q2 GAAP earnings per share $1.07 from continuing operations

* Q2 gaap earnings per share $1.07 from continuing operations

Select another date: